|
Incidence and multiplicity of colonic neoplasia. |
||||||||
| Group no. |
Treatment |
No. of mice |
Incidence (no. of mice with neoplasms) |
Multiplicity (no. of tumors/mice, means ± SD) |
||||
|
|
||||||||
| Total |
Adenoma |
Adeno-carcinoma |
Total |
Adenoma |
Adeno-carcinoma |
|||
|
|
||||||||
| 1 |
AOM/DSS |
10 |
10/10 (100%) |
10/10 (100%) |
10/10 (100%) |
5.2 ± 3.0 |
2.1 ± 1.8 |
3.0 ± 1.8 |
| 2 |
AOM/DSS/0.04% Nimesulide |
10 |
8/10 (80%) |
6/10 (60%)a |
4/10 (40%)b |
1.8 ± 1.7b |
1.2 ± 1.3 |
0.6 ± 1.0c |
| 3 |
AOM/DSS/0.05% Troglitazone |
10 |
9/10 (90%) |
9/10 (90%) |
4/10 (40%)b |
2.5 ± 1.8a |
1.6 ± 1.1 |
1.2 ± 2.5a |
| 4 |
AOM/DSS/0.05% Bezafibrate |
10 |
8/10 (80%) |
7/10 (70%) |
6/10 (60%)a |
2.6 ± 2.5a |
1.1 ± 1.0a |
1.8 ± 2.6 |
| 5 |
0.04% Nimesulide |
5 |
0/5 (0%) |
0/5 (0%) |
0/5 (0%) |
0 |
0 |
0 |
| 6 |
0.05% Troglitazone |
5 |
0/5 (0%) |
0/5 (0%) |
0/5 (0%) |
0 |
0 |
0 |
| 7 |
0.05% Bezafibrate |
5 |
0/5 (0%) |
0/5 (0%) |
0/5 (0%) |
0 |
0 |
0 |
| 8 |
AOM |
5 |
0/5 (0%) |
0/5 (0%) |
0/5 (0%) |
0 |
0 |
0 |
| 9 |
DSS |
6 |
0/6 (0%) |
0/6 (0%) |
0/6 (0%) |
0 |
0 |
0 |
| 10 |
None |
5 |
0/5 (0%) |
0/5 (0%) |
0/5 (0%) |
0 |
0 |
0 |
|
a,b,c Significantly different from group 1 by Fisher's exact probability test or Student's t-test (aP < 0.05, bP < 0.01, and c P < 0.005). | ||||||||
Kohno et al. BMC Cancer 2005 5:46 doi:10.1186/1471-2407-5-46 |
||||||||